Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague
Sign Up to like & getrecommendations! Published in 2022 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abg1787
Abstract: Gepotidacin is a first-in-class triazaacenaphthylene antibacterial agent that selectively inhibits bacterial DNA gyrase and topoisomerase IV through a unique binding mode and has the potential to treat a number of bacterial diseases. Development of this… read more here.
Keywords: pestis; pneumonic plague; plague; model pneumonic ... See more keywords